Form D · Biotechnology
Lodestone Biomedical, Inc.
Lebanon, NH · CIK 0001710677
Offering snapshot reported Jul 9, 2025 · SEC filing
- Reported sold
- $75K Offering amount: $2M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 29, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 9, 2025 | Initial | $75,000 | No comparison | 1 | SEC filing |
| Dec 14, 2021 | Initial | $450,000 | No comparison | 6 | SEC filing |
| Apr 6, 2020 | Initial | $110,000 | No comparison | 3 | SEC filing |
| Jul 13, 2017 | Initial | $550,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-551127
Source: Form D, filed Jul 9, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Solomon Diamond | Director, Executive |
| Lidia Valdes | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10 Water Street Suite 265
Lebanon, NH, 03766
Lebanon, NH, 03766